1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Investigación quirúrgica en urología y trasplante renal

Investigación quirúrgica en urología y trasplante renal

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Mínguez Ojeda C, Artiles Medina A, Fraile Poblador A, Sánchez González Á, Subiela Henríquez JD, Brasero Burgos J, de la Parra Sánchez I, López Curtis D, Del Olmo Durán P, Fernández-Mardomingo Díaz A, Jiménez Cidre MA, Gómez Dos Santos V, Burgos Revilla FJ.

    Analysis of device survival and predictive factors of failure in a cohort of patients with male artificial urinary sphincter.

    Actas Urologicas Espanolas . 49(6): 501786-501786.

    [doi:10.1016/j.acuroe.2025.501786]

  • Scilipoti P, Longoni M, de Angelis M, Zaurito P, Slusarczyk A, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Del Giudice F, Pichler R, Subiela JD, Marcq G, Gallioli A, Afferi L, Mastroianni R, Simone G, Albisinni S, Mertens LS, Laukhtina E, Oberneder K, Rodríguez Elena JL, Aranda J, Puentedura AL, Caño Velasco J, Contieri R, Hurle R, Mori K, Radziszewski P, Shariat SF, Gontero P, Necchi A, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M.

    Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancer

    BJU INTERNATIONAL . 136(1): 47-54. Nº de citas: 7

    [doi:10.1111/bju.16675]

  • Carnero-Alcázar M, Nuñez-Gil IJ, Vilacosta I, Montero L, Cuerpo G, Lopez-Menendez J, Feltes-Guzman G, Beltrao-Sial R, Pérez-Camargo D, Vicedo-López Á, Miranda-Torrón J, Solís-Chávez MB, Cobiella J, Maroto L.

    Need for a permanent pacemaker after transcatheter aortic valve implantation in Spain: a retrospective analysis of the national Minimum Basic Dataset from 2017 to 2022

    Open Heart . 12(1): .

    [doi:10.1136/openhrt-2025-003396]

  • Pichler R, van Creij NCH, Subiela JD, Cimadamore A, Caño-Velasco J, Tully KH, Mori K, Contieri R, Afferi L, Mari A, Soria F, Del Giudice F, D'Elia C, Mayr R, Mertens LS, Pyrgidis N, Moschini M, Gallioli A.

    Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease.

    Actas Urologicas Espanolas . 49(5): 501719-501719.

    [doi:10.1016/j.acuroe.2025.501719]

  • Scilipoti P, Longoni M, de Angelis M, Zaurito P, Massiet A, Dutto D, Soria F, Álvarez-Maestro M, Bazán AA, Pradere B, Klatte T, Contieri R, Hurle R, Krajewski W, Subiela JD, Pichler R, Szostek A, Marcq G, Elena JLR, Aranda J, Gontero P, Rouprêt M, Shariat SF, Necchi A, Montorsi F, Briganti A, Xylinas E, Moschini M.

    Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results

    BJU INTERNATIONAL . 135(6): 969-976. Nº de citas: 6

    [doi:10.1111/bju.16645]

  • Albers Acosta E, Pelari-Mici L, Celada Luis G, Velasco Balanza C, Zapatero A, Romero-Laorden N, Toquero Diez P, Caño-Velasco J, Guerrero-Ramos F, Moschini M, Krajewski W, Del Giudice F, Soria F, Laukhtina E, Mertens L, Pichler R, Mori K, D'Andrea D, Mari A, Marcq G, Teoh J, Afferi L, Albisinni S, Pradere B, Gallioli A, Subiela JD, San José Manso L.

    The impact of a multidisciplinary approach on treatment decisions and outcomes in urothelial carcinoma: A systematic review.

    Actas Urologicas Espanolas . 49(5): 501718-501718.

    [doi:10.1016/j.acuroe.2025.501718]

  • Mata M, Laso-García IM, Lorca-Álvaro J, Duque-Ruiz G, Arias-Fúnez F, Hevia M, López-Pérez E, Burgos-Revilla F.

    Auto-Expandable Metallic Ureteral Stents for Complex Ureteral Stenosis: Long-Term Outcomes in a Tertiary Institution

    UROLOGIA INTERNATIONALIS . 109(3): 285-290.

    [doi:10.1159/000542941]

  • Parente A, Verhoeff K, Wang Y, Wang N, Wang Z, Sledzinski M, Hellmann A, Raffaelli M, Pennestrì F, Sywak M, Papachristos AJ, Palazzo FF, Sung TY, Kim BC, Lee YM, Eatock F, Anderson H, Iacobone M, Daukša A, Makay O, Turk Y, Basut Atalay H, Nieveen van Dijkum EJM, Engelsman AF, Holscher I, Materazzi G, Rossi L, Becucci C, Shore SL, Fung C, Waghorn A, Mihai R, Balasubramanian SP, Pannu A, Tatarano S, Velázquez-Fernández D, Miller JA, Serrao-Brown H, Chen Y, Demarchi MS, Djafarrian R, Doran H, Wang K, Stechman MJ, Perry H, Hubbard J, Lamas C, Mercer P, MacPherson J, Lumbiganon S, Calatayud M, Alexandra Hanzu F, Vidal O, Araujo-Castro M, Minguez Ojeda C, Papavramidis T, Rodríguez de Vera Gómez P, Aldrees A, Altwjry T, Valdés N, Álvarez-Escola C, García Sanz I, Blanco Carrera C, Manjón-Miguélez L, De Miguel Novoa P, Recasens M, García Centeno R, Robles Lázaro C, Van Den Heede K, Van Slycke S, Michalopoulou T, Aspinall S, Melvin R, Lau JWL, Cheah WK, Tang MH, Oh HB, Ayuk J, Sutcliffe RP.

    Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma An International Multicenter Study

    European Urology Focus . 11(1): 118-125. Nº de citas: 6

    [doi:10.1016/j.euf.2024.09.001]

  • Santoni M, Roviello G, Grande E, De Giorgi U, Fiala O, Seront E, Molina-Cerrillo J, Pichler R, Myint ZW, Kucharz J, Kanesvaran R, Büttner T, Pichler M, Basso U, Kopecky J, Bourlon MT, Cerbone L, Buchler T, Pinto A, de Liaño AG, Gianni C, Zgura A, Rescigno P, Ansari J, Caffo O, Küronya Z, Vitale MG, Bhuva D, Catalano M, Vau N, Kopp RM, Buti S, Bamias A, Porta C, Sunela K, Massari F.

    Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

    CANCER IMMUNOLOGY IMMUNOTHERAPY . 74(7): 225-225. Nº de citas: 1

    [doi:10.1007/s00262-025-04043-x]

  • Gómez Rivas J, de la Parra I, Infante S, Ibañez L, Gutierrez Hidalgo B, Cabrera MN, Puente J, Sanmamed N, Ortega Polledo LE, Galante MI, Moreno Sierra J.

    Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) in Initial Staging of Prostate Cancer Patients: The Beginning of a New Era.

    MEDICINA-LITHUANIA . 61(5): .

    [doi:10.3390/medicina61050924]

  • Scilipoti P, Longoni M, de Angelis M, Zaurito P, Slusarczyk A, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Giudice FD, Pichler R, Subiela JD, Marcq G, Gallioli A, Afferi L, Mastroianni R, Simone G, Albisinni S, Mertens LS, Laukhtina E, Oberneder K, Rodríguez Elena JL, Aranda J, Puentedura AL, Velasco JC, Contieri R, Hurle R, Mori K, Radziszewski P, Shariat SF, Gontero P, Necchi A, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M.

    Long-term Oncological Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG Treatment.

    European Urology Focus . : . Nº de citas: 3

    [doi:10.1016/j.euf.2025.04.033]

  • Porta C, Massari F, Taha T, Grande E, Bourlon MT, Kanesvaran R, Basso U, Molina-Cerrillo J, Alonso-Gordoa T, Myint ZW, Fornarini G, Buttner T, Park SH, Ürün Y, De Giorgi U, Pichler R, Rescigno P, Buchler T, Studentova H, Melichar B, Ansari J, Mollica V, Kucharz J, Rizzo M, Rizzo A, Kopp RM, Buti S, Monteiro FSM, Soares A, Bamias A, Santoni M.

    Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON-1 study

    CANCER IMMUNOLOGY IMMUNOTHERAPY . 74(7): 196-196.

    [doi:10.1007/s00262-025-04019-x]

  • Alonso-Gordoa T, Anguera G, Domínguez-Esteban M, Reig Ò, Martínez-Barros H, Molina-Cerrillo J, Cruz P, Maroto P.

    Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategies.

    CANCER TREATMENT REVIEWS . 136: 102925-102925.

    [doi:10.1016/j.ctrv.2025.102925]

  • Rodríguez-Moreno JF, de Velasco G, Álvarez-Fernández C, Collado R, Fernández R, Vázquez S, Virizuela JA, Gajate P, Font A, Lainez N, Sevillano-Fernández E, Graña-Castro O, Beltrán L, Madurga R, Rodríguez-Antona C, Berraondo P, Ruiz-Llorente S, García-Donas J.

    Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial

    CLINICAL CANCER RESEARCH . 31(9): 1644-1656.

    [doi:10.1158/1078-0432.CCR-24-2890]

  • Laszkiewicz J, Del Giudice F, Li S, Krajewski W, Nowak L, Szydelko T, Basran S, De Berardinis E, Carino D, Corvino R, Santerelli V, Ferro M, Rocco B, Sighinolfi MC, Crocetto F, Barone B, Dinacci F, Pichler R, Subiela JD, Pradere B, Moschini M, Mari A, Gallioli A, Mori K, Soria F, Mertens L, Abu-Ghanem Y, Nair R, Khan MS, Chung BI.

    Novel risk factors for venous thromboembolism following outpatient or inpatient transurethral resection of bladder tumors: Multivariable stepwise and LASSO regression modeling from us insurance claim database.

    Actas Urologicas Espanolas . 49(4): 501738-501738.

    [doi:10.1016/j.acuroe.2025.501738]

  • Rivero Belenchón I, Congregado Ruíz CB, Gómez Ciriza G, Gómez Dos Santos V, Burgos Revilla FJ, Medina López RA.

    Impact of 3D-Printed Models for Surgical Planning in Renal Cell Carcinoma With Venous Tumor Thrombus: A Randomized Multicenter Clinical Trial.

    The Journal of urology . 213(5): 568-580.

    [doi:10.1097/JU.0000000000004425]

  • Gallioli A, Uleri A, Verri P, Tedde A, Mertens LS, Moschini M, Del Giudice F, Soria F, Laukhtina E, Subiela JD, Krajewski W, D'Andrea D, Mari A, Marcq G, Mori K, Teoh J, Afferi L, Albisinni S, Sanguedolce F, Palou J, Breda A, Pradere B.

    Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group

    European Urology Focus . 11(3): 482-495. Nº de citas: 3

    [doi:10.1016/j.euf.2025.01.009]

  • Artero Fullana S, Caño Velasco J, Lafuente Puentedura A, Polanco Pujol L, Bataller Monfort V, Moralejo Gárate M, Subiela JD, Gallioli A, Moschini M, Pichler R, Del Giudice F, Marcq G, Teoh J, Soria F, Mertens L, Krajewski W, Laukhtina E, Mori K, Pradere B, Afferi L, Tully KH, Albisinni S, Abu Ghanem Y, d'Andrea D, Mari A, Albers Acosta E, Contieri R, Cimadamore A, Grobet-Jeandin E, Gómez Rivas J, Hernández Fernández C.

    Diagnostic accuracy of Bladder EpiCheck for upper tract urothelial carcinoma: A meta-analysis.

    Actas Urologicas Espanolas . 49(4): 501720-501720.

    [doi:10.1016/j.acuroe.2025.501720]